Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions

Area of Science:

• Endocrinology
• Metabolic research
• Molecular biology

Background:

• Visfatin is a newly identified adipocyte hormone.
• It exhibits a direct correlation with plasma visfatin levels and type 2 diabetes mellitus.
• Visfatin functions distinctly from insulin, impacting glucose regulation.

Purpose of the Study:

• To elucidate the role of visfatin in glucose metabolism.
• To investigate the relationship between visfatin and type 2 diabetes mellitus.
• To explore visfatin's cellular localization and tissue distribution.

Main Methods:

• The abstract does not detail specific experimental methods.
• It summarizes existing knowledge on visfatin's biochemical properties and physiological effects.
• Comparative sequence analysis highlights the evolutionary conservation of the visfatin gene.

Main Results:

• Visfatin binds to the insulin receptor, distinct from insulin's binding site.
• It reduces hepatic glucose release and enhances glucose uptake in adipocytes and myocytes, leading to hypoglycemia.
• Visfatin is upregulated by hypoxia, inflammation, and hyperglycemia, and downregulated by insulin and statins.
• It is expressed in various tissues, with preferential localization in visceral adipose tissue.
• Visfatin acts as an endocrine, autocrine, and paracrine peptide with diverse functions.

Conclusions:

• Visfatin plays a significant role in glucose homeostasis.
• Its association with type 2 diabetes mellitus warrants further investigation.
• More comprehensive studies are required to fully understand visfatin's etiological and pathogenetic contributions to type 2 diabetes mellitus.